Mark Jacobson, M.A
2019
In 2019, Mark Jacobson, M.A earned a total compensation of $2M as Chief Operating Officer at Axsome Therapeutics, a 321% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,750 |
|---|---|
| Option Awards | $1,482,931 |
| Salary | $310,000 |
| Total | $1,955,681 |
MA received $1.5M in option awards, accounting for 76% of the total pay in 2019.
MA also received $162.8K in non-equity incentive plan and $310K in salary.
Rankings
In 2019, Mark Jacobson, M.A's compensation ranked 6,052nd out of 13,971 executives tracked by ExecPay. In other words, MA earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,052 out of 13,971 | 57th |
Division Manufacturing | 2,270 out of 5,695 | 60th |
Major group Chemicals And Allied Products | 820 out of 2,194 | 63rd |
Industry group Drugs | 693 out of 1,880 | 63rd |
Industry Pharmaceutical Preparations | 511 out of 1,392 | 63rd |
Pay ratio
| Mark Jacobson, M.A's Pay | $1,955,681 |
|---|---|
| Median Employee's Pay | $166,021 |
| Pay Ratio | to 1 |
In 2019, the annual total compensation of Mark Jacobson, M.A was $1,955,681.
The annual total compensation of the median employee at Axsome Therapeutics was $166,021.
The ratio of Mark Jacobson, M.A's pay to the pay of median employee was therefore to one.
Source: SEC filing on April 23, 2021.
MA's colleagues
We found three more compensation records of executives who worked with Mark Jacobson, M.A at Axsome Therapeutics in 2019.